Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-10

Clinical Trial Update: Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers [Phase 2]

View source ↗

Summary

Phase 2 study evaluating adoptive transfer of tumor-infiltrating lymphocytes (TIL) for advanced solid cancers, with multiple site-specific indications including…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tumor-infiltrating lymphocyte (TIL) therapy

Snippet

Sponsor: Udai Kammula | Conditions: Gastric Cancer, Colorectal Cancer | Phase 2 | Status: RECRUITING